Actively Recruiting
Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
Led by Vastra Gotaland Region · Updated on 2025-11-21
300
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective multicenter observational study evaluates whether women ≥50 years with isolated acute hemorrhagic cystitis (AHC) and macroscopic hematuria require full malignancy workup. All participants undergo standard diagnostics (cystoscopy, CT urography, cytology), with 12-month follow-up for cancer detection. The aim is to identify low-risk patients where invasive investigations may be safely avoided.
CONDITIONS
Official Title
Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women 50 years of age or older
- Visible blood in the urine (macroscopic hematuria)
- Presenting for evaluation within the specialized care program for macroscopic hematuria
- Ability to provide informed consent
You will not qualify if you...
- Prior diagnosis of bladder cancer, kidney cancer, or upper urinary tract urothelial carcinoma
- Cognitive impairment preventing informed consent
- Ongoing or recent treatment for urological malignancy
- Serious comorbidities affecting participation or safety
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Uddevalla Hospital
Uddevalla, Sweden, 45 198
Actively Recruiting
Research Team
S
Suleiman Abuhasanein, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here